期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF ONCOLOGY PHARMACY PRACTICE LetPub Score 5.1
50 ratings
Rate
Reputation 6.3 Influence 3.9 Speed 7.1 | ||||||||||||||||||||
期刊簡稱 | J ONCOL PHARM PRACT | ||||||||||||||||||||
ISSN | 1078-1552 | ||||||||||||||||||||
E-ISSN | 1477-092X | ||||||||||||||||||||
h-index | 28 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 10.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://journals.sagepub.com/home/opp | ||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/jopp | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | SAGE Publications Ltd | ||||||||||||||||||||
主題領域 | Medicine | ||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 239每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 6.45% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1078-1552%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[JOURNAL OF ONCOLOGY PHARMACY PRACTICE] 的評論 | 撰寫評論 |
作者: 太虚诗翠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-17 09:11:28 評論於 Have any of the experts encountered a situation where there is no option to select a corresponding author when submitting a manuscript?(0) 讚! | 太虚诗翠 |
作者: George Dunbar 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-05 10:41:37 評論於 How can I successfully submit my work in the end?(0) 讚! | George Dunbar |
作者: 仲夏梓涵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-06 11:52:11 評論於 Have you been hired?(0) 讚! | 仲夏梓涵 |
作者: 小杨同学 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2022-05-03 23:46:56 評論於 Research on anti-tumor drugs, pure cells, rejected within one day, reason being the journal does not accept preclinical research.(0) 讚! | 小杨同学 |
作者: 小令璟吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-08 19:50:19 評論於 The submission interface of this magazine is very frustrating, and I have been unable to submit it due to various system issues. Submit cautiously(0) 讚! | 小令璟吖 |
作者: 是士懿吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-02 12:10:35 評論於 Review Speed: 2.0 | Submission Acceptance Rate: 50.0 Experience Sharing: The Journal of Oncology Pharmacy Practice conducts comprehensive and rigorous evaluations of drug use in cancer patient care. Reports on systemic policy on medication, outcome indicators, innovative services, policy and outcome evaluation tools. Brief commentaries on articles published in the journal or other interesting information. Opinions on controversial areas of treatment and practice-related issues. An indispensable medical journal to assist your practice(0) 讚! | 是士懿吖 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us